Why are generic pharmaceuticals significantly cheaper than...

Labs

Want to see this concept in action?

NEW

Explore this concept interactively to see how it behaves as you change inputs.

View Labs

Key Concepts

Generic Pharmaceuticals

Generic pharmaceuticals are drugs that contain the same active ingredients as their name brand equivalents once the original product's patent expires. Because they do not bear the initial research, development, and extensive clinical trial costs that are associated with branded drugs, generic manufacturers can offer them at a lower price, making them more affordable to consumers.

Patent Protection and Exclusivity

Patent protection grants name brand drug manufacturers a period of exclusivity during which they can recoup their significant investments in research and development, marketing, and regulatory approval. Once this patent period expires, other manufacturers are allowed to produce the generic versions, intensifying market competition and further driving down the cost.

Regulatory Approval and Bioequivalence

Although generic pharmaceuticals bypass the high costs of original research and development, they must undergo regulatory assessments to prove that their performance, safety, and efficacy are equivalent to the name brand versions. This process of establishing bioequivalence ensures that the generic drugs provide the same therapeutic benefits while allowing them to be priced more competitively in the market.

Transcript

Please give Ace some feedback